Untitled

• .

Today's Learning Focus

• Topic: Transdermal Drug Delivery

  • This session will review slight modifications in the dosage forms of drugs, specifically how they are engineered for effective transdermal delivery. This includes considerations like drug solubility, vehicle formulation, and patch design.

Review of Previous Concepts

• Concepts from Modified Release Dosage Forms, such as controlled and sustained release mechanisms, will be revisited. This will be in the context of how these principles apply to the design and function of transdermal patches to achieve desired drug release profiles and therapeutic durations.

• A detailed discussion of enhancement methods in transdermal drug delivery systems will also be included, exploring both chemical and physical strategies to improve drug permeation through the skin.

Anatomy of the Skin

• The skin is the largest organ of the body, characterized by its extensive surface area, typically about $1.7 m^2$, and a rich blood supply, which is crucial for nutrient delivery and drug absorption into systemic circulation.

• Structure: The skin is composed of three primary layers:

  • Epidermis (outermost): This is the outermost protective layer, primarily composed of keratinocytes, and acts as the body's first line of defense against environmental insults and pathogens.

  • Dermis (middle layer): Located beneath the epidermis, the dermis is thicker and contains vital structures such as hair follicles, sweat glands (responsible for thermoregulation), nerve fibers (for sensation), and sebaceous glands (producing sebum).

  • Hypodermis (innermost): Also known as the subcutaneous tissue, this layer is composed mainly of adipose (fat) tissue, providing insulation, energy storage, and shock absorption.

Epidermis Details

• The epidermis is predominantly composed of keratinized squamous cells, which continually differentiate and migrate upwards.

• Stratum Corneum:

  • This is the outermost layer of the epidermis and serves as the primary and most significant barrier for drug penetration. It consists primarily of dead, flat, keratinized cells (corneocytes) that are enucleated and tightly packed, resembling bricks in a wall (the "Brick and Mortar" model).

  • The entire stratum corneum layer is shed and replaced approximately every 14 days through a process called desquamation. This constant turnover impacts long-term drug delivery strategies.

Comparison of Topical vs. Transdermal Drug Delivery

• Topicals: These formulations are applied to the skin with the specific aim of achieving localized therapeutic effects at or near the application site, such as treating eczema or fungal infections, without significant systemic absorption.

• Transdermal: In contrast, transdermal drug delivery systems are designed for drugs to penetrate through the skin layers and actively enter the systemic circulation to exert effects throughout the body, bypassing the gastrointestinal tract.

Advantages of Transdermal Drug Delivery

• Bypasses hepatic first-pass metabolism: Drugs delivered transdermally avoid initial degradation by liver enzymes, leading to higher bioavailability and potentially lower doses.

• Avoids gastrointestinal (GI) tract hurdles: This route circumvents challenges associated with oral administration, including:

  • Variable pH levels: Protection from degradation in the acidic stomach or alkaline small intestine.

  • Presence of digestive enzymes: Avoidance of enzymatic breakdown by gastric or intestinal enzymes.

  • Hepatic first-pass effects: Similar to bypassing direct liver metabolism, this also prevents extensive drug metabolism occurring immediately after GI absorption.

• Suitable for patients unable to take oral medications: Ideal for patients who are unconscious, experiencing nausea and vomiting, or have difficulty swallowing.

• Improved patient compliance: Achieved due to significantly lower dosing frequency, often requiring application only once daily or every few days, which simplifies medication regimens.

• Clear identification of medication: Patches can be labeled with drug name and strength, making it easy for patients and caregivers to identify the medication and monitor adherence. Additionally, drug therapy can be easily terminated by removing the patch.

Disadvantages and Limitations

• Possible skin allergies: Patients may develop allergic reactions or irritation to the adhesive materials, excipients, or the drug itself, leading to discomfort or discontinuation of therapy.

• Limitations imposed by the need for passive diffusion: The stratum corneum restricts the passage of many molecules, making it:

  • Not suitable for large molecules: Generally, molecules with molecular weights over $500 Da$ struggle to penetrate effectively.

  • Not suitable for highly polar molecules: highly hydrophilic compounds do not readily cross the lipid-rich stratum corneum.

• Dose Limitation:

  • This delivery system requires highly potent drugs that can achieve therapeutic blood concentrations with a relatively low dosage delivered through the skin. This is because the skin's absorption capacity is finite, and only a limited amount of drug can permeate per unit area over time. The maximum daily dose from a patch is typically around $10-20 mg$.

• Production complexity: The manufacturing of transdermal patches can be complex, involving precise control over drug loading, release kinetics, adhesive properties, and backing membrane characteristics.

Mechanisms of Drug Penetration through Skin

Key Pathways

1. Transcellular Pathway (Intracellular):

   • In this pathway, the drug molecules pass directly through the horny cells (corneocytes) of the Stratum Corneum. This route requires the drug to partition into and diffuse through both the lipid membrane of the cells and the intracellular matrix, then out through the subsequent cell.

2. Paracellular Pathway (Intercellular):

   • The drug moves between the skin cells, primarily through the lipid lamellae (mortar) that surround the corneocytes (bricks) in the Stratum Corneum. This is often described as a zigzag path through the intercellular lipid matrix and is the predominant route for many lipophilic drugs.

3. Shunt Pathway (Appendageal):

   • This pathway involves drug transport through physiological shunts like hair follicles and sweat glands. While these routes offer direct access to the deeper dermal layers, they represent a very small surface area ($0.1\% - 1\%$) compared to the intact stratum corneum, thus contributing less significantly to overall drug penetration for most compounds, especially for long-term delivery.

Drug Diffusion Models

• Brick and Mortar Model (for Stratum Corneum):

  • This widely accepted model depicts the stratum corneum as a structure where dead, flattened skin cells (corneocytes) act as "bricks" and are embedded in a continuous, extracellular lipid matrix (composed of ceramides, cholesterol, and free fatty acids) acting as the "mortar." Drugs can diffuse through either the lipid layers (often a tortuous, zigzag path for lipophilic drugs) or directly through the cells (a more linear path, favored by hydrophilic drugs), or a combination of both.

Drug Properties Influencing Transdermal Penetration

• Ideal molecular weight for effective transdermal drugs is generally considered to be less than $400$ to $500 Da$. This is because smaller molecules can more readily navigate the constricted pathways within the stratum corneum.

• A critical balance of lipophilicity and hydrophilicity is required for optimal skin penetration:

  • Aqueous solubility: Necessary for the drug to dissolve in the formulation and be released to the skin surface to initiate contact and partitioning into the stratum corneum.

  • Lipid solubility: Essential for the drug to partition into and diffuse through the lipid-rich intercellular matrix of the stratum corneum, which is the primary barrier for penetration.

• Partition coefficient (logP) values between $1$ and $3$ are generally considered optimal for transdermal drug candidates.

Candidate Drugs

• Suitable candidates: Typically include low molecular weight (e.g., < $400 Da$), potent drugs with appropriate balanced solubility for both aqueous vehicles and lipid skin barriers. Examples include nitroglycerin, fentanyl, scopolamine, and nicotine.

  • Hydrophilic drugs generally favor the transcellular route.

  • Lipophilic drugs tend to promote penetration via the paracellular route.

• Challenges for transdermal delivery: Significant limitations exist for large ($>500 Da$), highly polar, or highly ionized molecules due to their inability to effectively cross the stratum corneum barrier.

Factors Affecting Transdermal Penetration

Several factors significantly influence the rate and extent of drug penetration through the skin:

1. Drug Properties:

   • Solubility: The ability to dissolve in both the formulation vehicle and the skin lipids is crucial.

   • Molecular weight: Smaller molecules permeate more easily.

   • Ionization states: Unionized forms of drugs generally penetrate the skin more readily than ionized forms since they are more lipophilic.

2. Skin Properties:

   • Thickness of stratum corneum: Thinner stratum corneum (e.g., post-auricular region behind the ears, scrotum) promotes better absorption. Areas like the palms and soles have thicker stratum corneum and are less suitable.

   • Hydration state: Hydrated skin is more permeable than dry skin, as water can swell the corneocytes and disrupt the lipid packing.

   • Skin integrity: Damaged or broken skin is significantly more permeable, but this can lead to unpredictable absorption and potential irritation.

   • Blood flow: Increased local blood flow can enhance the removal of absorbed drug, maintaining a higher concentration gradient across the skin.

3. Formulation Factors:

   • Vehicles: The choice of vehicle (e.g., gels, creams, patches) is critical in facilitating optimal skin contact, ensuring drug stability, and controlling release kinetics. Vehicles can influence drug partitioning into the skin.

   • Moisture retention (occlusion): Occlusive patches or dressings can increase skin hydration, thereby enhancing permeability.

   • Special excipients: The inclusion of penetration enhancers (e.g., surfactants, solvents, fatty acids) can significantly alter the stratum corneum barrier properties to increase drug flux.

Enhancement Methods in Transdermal Drug Delivery

To overcome the formidable barrier function of the stratum corneum, various enhancement methods have been developed:

1. Chemical Enhancement:

   • Involves the use of chemical agents (penetration enhancers) that reversibly alter the structural properties of the stratum corneum to increase its permeability. Examples include surfactants (e.g., sodium lauryl sulfate), fatty acids (e.g., oleic acid), alcohols (e.g., ethanol), and sulfoxides (e.g., dimethyl sulfoxide - DMSO).

   • Facilitates drug solubility within the formulation and its partitioning into the skin.

   • Mechanisms: These enhancers work through several proposed mechanisms:

     • Intercalation into lipid layers: Disrupting the tightly packed intercellular lipid bilayers, increasing their fluidity and creating more pathways.

     • Dissolving lipid structures: Extracting or solubilizing intercellular lipids, thereby reducing barrier integrity.

     • Interaction with keratin fibers: Affecting the conformation of keratin in corneocytes, potentially increasing their water content and creating transient aqueous channels.

2. Physical Enhancement:

   • These methods utilize various forms of energy or mechanical disruption to temporarily reduce the skin's barrier function:

     • Iontophoresis: Applies a low-level electric current to the skin to enhance the transdermal transport of ionized drug molecules. Similar charges repel, pushing the drug through the skin. It improves delivery for charged molecules that struggle with passive diffusion.

     • Electroporation: Involves applying short, high-voltage electrical pulses to the skin, temporarily creating aqueous pores or defects within the stratum corneum lipid bilayers, allowing larger molecules to pass through.

     • Sonophoresis (Phonophoresis): Utilizes low-frequency ultrasound waves to induce thermal and mechanical effects, generating microbubbles (cavitation) that disrupt skin lipids and increase drug diffusion. It can also create convective transport.

     • Microneedles: Consist of arrays of tiny needles (typically 25-1500 microns in length) that painlessly penetrate the stratum corneum to create micro-channels in the skin. These channels bypass the main barrier without reaching nerve endings, allowing for targeted and controlled drug delivery of a wider range of molecules, including large proteins and vaccines.

Future Directions

• The field is moving towards combining multiple strategies to achieve synergistic enhancement effects. For instance, integrating microneedles with iontophoresis or electroporation could offer more efficient and controlled delivery of challenging drug molecules, potentially broadening the scope of transdermal applications.

Commercial Products

• Transdermal Scopolamine (Trad. name: Transderm Scōp) (Approved 1979 in the US, earlier in 1975 in Canada): This patch is famously used for the prevention of motion sickness and nausea. It is typically designed to deliver scopolamine (a potent anticholinergic) consistently for three days, highlighting its capacity for sustained release and relatively high drug quantities within the patch matrix.

• Transdermal Nicotine Patches: Widely utilized as an aid for smoking cessation. These patches deliver nicotine systemically, but in tapering doses over several weeks or months. This strategy aims to gradually reduce physical dependence on nicotine, minimizing withdrawal symptoms while the patient works on behavioral aspects of quitting smoking.

Key Takeaways

• Transdermal systems represent a sophisticated approach to managing large, continuously required dosages while effectively circumventing various complications associated with traditional administration routes, particularly oral uptake. These innovative delivery systems are meticulously optimized to significantly improve patient adherence through a combination of advanced formulation strategies and cutting-edge technologies that enhance skin permeability. A comprehensive understanding of the intricate physical, chemical, and biological processes involved in skin permeation is fundamentally crucial for the rational design and successful development of highly effective transdermal drug delivery systems.